Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG

Approved

STANDARD

ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 18, 2024
Approval ID: c4e8beb6a582e8cc
Company: Glenmark Arzneimittel Gmbh
Type: Standard

Approval Details

Approval Id: c4e8beb6a582e8cc
Drug Cima Aemps Name: ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number: 89251
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2024-01-18
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 0,44 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

Company Information

Pharmaceutical Company Name: Glenmark Arzneimittel GmbH
Country Name: Germany
Website: http://www.glenmark.de

Active Ingredients

ERIBULINA MESILATO

0,5 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 18, 2024

Approval ID

c4e8beb6a582e8cc

Type

Standard

Back to CIMA-AEMPS Approvals